Global non-viral gene transfer to the promate brain following intravenous administration

Molecular Therapy

Volumn 7, Issue 1, 2003, Pages 11-18

  Zhang, Yun ^a   Schlachetzki, Felix ^a,b   Pardridge, William M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

Blood brain barrier; Gene therapy; Insulin receptor; Liposomes; Non viral gene transfer

Indexed keywords

BETA GALACTOSIDASE; INSULIN RECEPTOR; INSULIN RECEPTOR ANTIBODY; LIPOSOME; LUCIFERASE; MACROGOL; MONOCLONAL ANTIBODY; PLASMID DNA;

ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DRUG TRANSPORT; ENCAPSULATION; ENDOCYTOSIS; EXPRESSION VECTOR; FEASIBILITY STUDY; GENE EXPRESSION; GENE TARGETING; GENETIC CODE; HISTOCHEMISTRY; NERVE CELL MEMBRANE; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; RHESUS MONKEY; TRANSCYTOSIS; TRANSGENICS;

ANIMALIA; MACACA MULATTA; PRIMATES; VECTORS;

EID: 0037222013     PISSN: 15250016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1525-0016(02)00018-7     Document Type: Article

References (23)

1. Martin, J. B. (1995). Gene therapy and pharmacological treatment of inherited neurological disorders. Trends Biotechnol 13: 28-35.
2. Shi, N., and Pardridge, W. M. (2000). Non-invasive gene targeting to the brain. Proc. Natl. Acad. Sci. USA 97: 7567-7572.
3. Mok, K. W. C., Lam, A. M. I., and Cullis, P. R. (1999). Stabilized plasmid-lipid particles: factors influencing plasmid entrapment and transfection properties. Biochem. Biophys. Acta 1419: 137-150.
4. Semple, S. C., Chonn, A., and Cullis, P. R. (1998). Interactions of liposomes and lipid-based carrier systems with blood proteins: relation to clearance behaviour in vivo. Adv. Drug Deliv. Rev. 32: 3-17.
5. Pardridge, W. M. (2001). Brain Drug Targeting; The Future of Brain Development. Cambridge University Press, Cambridge, United Kingdom, 1-370.
6. Shi, N., Zhang, Y., Boado, R. J., Zhu, C., and Pardridge, W. M. (2001). Brain-specific expression of an exogenous gene following intravenous administration. Proc. Natl. Acad. Sci. USA 98: 12754-12759.
7. Shi, N., Boado, R. J., and Pardridge, W. M. (2001). Receptor-mediated gene targeting to tissues in the rat in vivo. Pharm. Res. 18: 1091-1095.
8. Zhu, C., Zhang, Y., and Pardridge, W. M. (2002). Widespread expression of an exogenous gene in the eye following intravenous administration. Invest. Ophthalmol. Vis. Sci. 43: 3075-3080.
9. Strayer, D. S. (1996). SV40 as an effective gene transfer vector in vivo. J. Biol. Chem. 271: 24741-24746.
10. Zhang, Y., Zhu, C., and Pardridge, W. M. (2002). Antisense gene therapy of brain cancer with an artificial virus gene delivery system. Mol. Ther. 6: 67-72.
11. Zhang, Y., Boado, R. J., Pardridge, W. M. (2003). Marked enhancement in gene expression by targeting the human insulin receptor. J. Gene Med., in press.
12. Zhang, Y., Lee, H. J., Boado, R. J., and Pardridge, W. M. (2002). Receptor-mediated delivery of an antisense gene to human brain cancer cells. J. Gene Med. 4: 183-194.
13. Lierse, W., and Horstmann, E. (1959). Quantitative anatomy of the cerebral vascular bed with especial emphasis on homogeneity and inhomogeneity in small parts of the gray and white matter. Acta. Neurol. 14: 15-19.
14. Nevo, N., Chossat, N., Gagnach, W., Logeart, D., Mercadier, J.-J., and Michel, J.-B. (2001). Increasing endothelial cell permeability improves the efficiency of myocyte adenoviral vector infection. J. Gene Med. 3: 42-50.
15. Hong, K., Zheng, W., Baker, A., and Papahadjopoulos, D. (1997). Stabilization of cationic liposome-plasmid DNA complexes by polyamines and poly(ethlene glycol)-phospholipid conjugates for efficient in vivo gene delivery. FEBS Lett. 400: 233-237.
16. Plank, C., Tang, M. X., Wolfe, A. R., and Szoka, F. C. Jr. (1999). Branched cationic peptides for gene delivery: role of type and number of cationic residues in formation and in vitro activity of DNA polyplexes. Hum. Gene Ther. 10: 319-332.
17. Boado, R. J., and Pardridge, W. M. (1998). Ten nucleotide cis element in the 3′-untranslated region of the GLUT1 glucose transporter mRNA increases gene expression via mRNA stabilization. Mol. Brain Res. 59: 109-113.
18. Peng, K.-W., Pham, L., Ye, H., Zufferey, R., Trono, D., Cosset, F.-L., and Russell, S. J. (2001). Organ distribution of gene expression after intravenous infusion of targeted and untargeted lentiviral vectors. Gene Ther. 8: 1456-1463.
19. Coloma, M. J., Lee, H. J., Kurihara, A., Landaw, E. M., Boado, R. J., Morrison, S. L., and Pardridge, W. M. (2000). Transport across the primate blood-brain barrier of a genetically engineered chimeric monoclonal antibody to the human insulin receptor. Pharm. Res. 17: 266-274.
20. Zhang, Y., Calon, F., Zhu, C., Boado, R. J., Pardridge, W. M. (2003). Intravenous non-viral gene therapy causes normalization of striatal tyrosine hydroxylase and reversal of motor impairment in experimental Parkinsonism. Human Gene Therapy 14: 1-12.
21. Chen, Z.-Y., Yant, S. R., He, C.-Y., Meuse, L., Shen, S., and Kay, M. A. (2001). Linear DNAs concatemerize in vivo and result in sustained transgene expression in mouse liver. Mol. Ther. 3: 403-410.
22. 1-antitrypsin in mice. Mol. Ther. 4: 122-129.
23. Monnard, P.-A., Oberholzer, T., and Luisi, P. L. (1997). Entrapment of nucleic acids in liposomes. Biochem. Biophys. Acta 1329: 39-50.